AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34863136 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Health Behaviour Change (MHBC) intervention
Number of subjects: 3062
Study 34863136 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 3062
Study 35427363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily)
Number of subjects: 2300
Study 35427363 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 2300
Study 35427363 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 2300
Study 34090495 — intervention group
Group type: EXPERIMENTAL
Intervention: Online events for sharing trial results
Number of subjects: 0
Study 34704877 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D2 40,000 IU/week
Number of subjects: 80
Study 34704877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 34189336 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine-free alternatives
Number of subjects: 29
Study 34189336 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine-free and sugar-free alternatives
Number of subjects: 29
Study 34189336 — intervention group
Group type: COMPARATOR
Intervention: Caffeinated sugary drinks (control)
Number of subjects: 29
Study 34189336 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 29
Study 35361380 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (n = 18)
Number of subjects: 60
Study 35361380 — intervention group
Group type: COMPARATOR
Intervention: No DHEA supplementation (n = 20)
Number of subjects: 60
Study 32089148 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention to Promote Service Engagement (BIPSE)
Number of subjects: 0
Study 34985973 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 to 30 mg of arbaclofen (GABAB receptor agonist)
Number of subjects: 44
Study 34985973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 33887429 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided regional anesthesia (US‐RA)
Number of subjects: 78
Study 33887429 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 78
Study 33198286 — intervention group
Group type: EXPERIMENTAL
Intervention: Group citizenship behavior with high environmental dynamism
Number of subjects: 339
Study 33198286 — intervention group
Group type: EXPERIMENTAL
Intervention: Group citizenship behavior with low environmental dynamism
Number of subjects: 339
Study 33198286 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of group citizenship behavior and environmental dynamism
Number of subjects: 339
Study 35870425 — intervention group
Group type: EXPERIMENTAL
Intervention: Office hysteroscopy with endometrial scratch
Number of subjects: 0
Study 35870425 — intervention group
Group type: COMPARATOR
Intervention: Office hysteroscopy
Number of subjects: 0
Study 34160294 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect‐TOLF
Number of subjects: 30
Study 32764951 — intervention group
Group type: EXPERIMENTAL
Intervention: CAVI above the predicted value
Number of subjects: 163
Study 32764951 — intervention group
Group type: COMPARATOR
Intervention: CAVI predicted values by age and sex
Number of subjects: 163
Study 36149118 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-fowler's position
Number of subjects: 450
Study 36149118 — intervention group
Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 450
Study 36149118 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 450
Study 33041200 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist phone call intervention
Number of subjects: 0
Study 33041200 — intervention group
Group type: COMPARATOR
Intervention: No pharmacist phone call intervention (Control)
Number of subjects: 0
Study 33041200 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of the first dose to the patient
Number of subjects: 0
Study 33559294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 750mg once daily
Number of subjects: 200
Study 33559294 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin 400mg twice daily
Number of subjects: 200
Study 36200143 — intervention group
Group type: EXPERIMENTAL
Intervention: BlockBuster group (n = 351)
Number of subjects: 651
Study 36200143 — intervention group
Group type: COMPARATOR
Intervention: Supreme group (n = 300)
Number of subjects: 651
Study 33550515 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 min/bed position (bp) acquisition
Number of subjects: 21
Study 33550515 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min/bed position (bp) acquisition
Number of subjects: 21
Study 33550515 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 s/bed position (bp) acquisition
Number of subjects: 21
Study 33550515 — intervention group
Group type: EXPERIMENTAL
Intervention: All acquisition times
Number of subjects: 21
Study 32203684 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 303
Study 34524953 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue intervention strategy (RIS) with budesonide/formoterol plus original treatment until severe pollution ended
Number of subjects: 22
Study 34524953 — intervention group
Group type: COMPARATOR
Intervention: Control group maintained on original treatment
Number of subjects: 22
Study 32138842 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial neutrophil extract (ANE)
Number of subjects: 0
Study 32138842 — intervention group
Group type: COMPARATOR
Intervention: Osteochondral implantation
Number of subjects: 0
Study 35820804 — intervention group
Group type: EXPERIMENTAL
Intervention: QLB (quadratus lumborum block)
Number of subjects: 80
Study 35820804 — intervention group
Group type: COMPARATOR
Intervention: NS (normal saline)
Number of subjects: 80
Study 33683822 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic offsets derived from Gradient Forests (GF)
Number of subjects: 0
Study 33683822 — intervention group
Group type: EXPERIMENTAL
Intervention: Candidate SNPs
Number of subjects: 0
Study 33683822 — intervention group
Group type: COMPARATOR
Intervention: Naive climate transfer distances
Number of subjects: 0
Study 33003338 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Food Breakfast (FB)
Number of subjects: 16
Study 33003338 — intervention group
Group type: COMPARATOR
Intervention: Control Breakfast (CB)
Number of subjects: 16
Study 33003338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-eat Breakfast Cereal (RTEC)
Number of subjects: 16
Study 35877016 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing process based on King’s Theory of Goal Attainment (TGA) implemented for 1 month.
Number of subjects: 70
Study 35877016 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 70
Study 33927112 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional-set structure (TRAD, n = 10)
Number of subjects: 21
Study 33927112 — intervention group
Group type: COMPARATOR
Intervention: Cluster-set structure (CLUS, n = 11)
Number of subjects: 21
Study 33573681 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine 2% (20mg/mL)
Number of subjects: 100
Study 33573681 — intervention group
Group type: COMPARATOR
Intervention: Intravenous NaCl 0.9% (9 mg/mL)
Number of subjects: 100
Study 35165105 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentivised-peer-networks distributing HIVST packs with HIV prevention information
Number of subjects: 45
Study 35165105 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct distribution of HIVST packs by peer navigators
Number of subjects: 45
Study 35165105 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care peer navigators distributing information without HIVST kits
Number of subjects: 45
Study 34635372 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D Delta Plate
Number of subjects: 20
Study 34635372 — intervention group
Group type: COMPARATOR
Intervention: Conventional miniplates
Number of subjects: 20
Study 34208986 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein snack (HP), n = 52, containing 50 g soybean
Number of subjects: 107
Study 34208986 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric low-protein snack (LP), n = 55
Number of subjects: 107
Study 32661522 — intervention group
Group type: EXPERIMENTAL
Intervention: DFDBA after intramarrow penetration along with open flap debridement (OFD+IMP+ DFDBA)
Number of subjects: 40
Study 32661522 — intervention group
Group type: COMPARATOR
Intervention: DFDBA along with open flap debridement (OFD+DFDBA)
Number of subjects: 40
Study 33152169 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture stent
Number of subjects: 88
Study 33152169 — intervention group
Group type: COMPARATOR
Intervention: Standard ureteric stent
Number of subjects: 88
Study 32591594 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus cold atmospheric plasma (SC + CAP)
Number of subjects: 44
Study 32591594 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 44
Study 32591594 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP)
Number of subjects: 44
Study 36273182 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally secure intervention involving training in culturally safe care and enhanced support from Aboriginal Brain Injury Coordinators.
Number of subjects: 108
Study 36273182 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no intervention).
Number of subjects: 108
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% deltamethrin
Number of subjects: 20
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% bendiocarb
Number of subjects: 20
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% pirimiphos‐methyl
Number of subjects: 20
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% DDT
Number of subjects: 20
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperonyl butoxide (PBO) pre-exposure
Number of subjects: 20
Study 32618244 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sporozoite infection rate
Number of subjects: 20
Study 35597993 — intervention group
Group type: EXPERIMENTAL
Intervention: AMS ENGAGEMENT bundle (multimodal multi-disciplinary interventions including education for nurses and general practitioners, telehealth support, and formation of an antimicrobial stewardship team)
Number of subjects: 18
Study 35597993 — intervention group
Group type: COMPARATOR
Intervention: Usual care processes for antibiotic use and stewardship (control group)
Number of subjects: 18
Study 33524515 — intervention group
Group type: EXPERIMENTAL
Intervention: ODRA plus usual care (ODRA group)
Number of subjects: 120
Study 33524515 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (UCA group)
Number of subjects: 120
Study 33958501 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo 'energy drink' (deliberate positive information)
Number of subjects: 17
Study 33958501 — intervention group
Group type: COMPARATOR
Intervention: Regular water (standard information)
Number of subjects: 17
Study 32311627 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter (outpatient)
Number of subjects: 695
Study 34323589 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mmol/kg gadoteridol at a rate of 3 mL/s (group A)
Number of subjects: 85
Study 34323589 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mmol/kg gadoteridol at a rate of 2 mL/s (group B)
Number of subjects: 85
Study 34666875 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting distant metastasis risk based on independent risk factors.
Number of subjects: 411
Study 32359021 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel yeast extract
Number of subjects: 60
Study 32359021 — intervention group
Group type: COMPARATOR
Intervention: Colloidal oatmeal lotion (Aveeno™ Eczema Therapy Moisturizing Cream)
Number of subjects: 60
Study 33067295 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based patient-primary care physician-cardiologist integrated management model of hypertension (RSCDMS)
Number of subjects: 0
Study 33067295 — intervention group
Group type: COMPARATOR
Intervention: Traditional care group
Number of subjects: 0
Study 36079816 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐day fasting followed by 10 weeks of lifestyle modification (F + LM; n = 73)
Number of subjects: 145
Study 36079816 — intervention group
Group type: COMPARATOR
Intervention: 10 weeks of lifestyle modification only (LM; n = 72)
Number of subjects: 145
Study 33208263 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK‐A (Ar cold plasma treatment)
Number of subjects: 4
Study 33208263 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK‐N (N2 cold plasma treatment)
Number of subjects: 4
Study 33208263 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK‐AN (90% Ar and 10% N2 mixed cold plasma treatment)
Number of subjects: 4
Study 33208263 — intervention group
Group type: COMPARATOR
Intervention: PEEK‐C (untreated)
Number of subjects: 4
Study 32139455 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 309
Study 35720377 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (n = 30)
Number of subjects: 59
Study 35720377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 59
Study 35949401 — intervention group
Group type: EXPERIMENTAL
Intervention: Care navigation intervention
Number of subjects: 46
Study 35949401 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 46
Study 32969489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 2 mg kg−1
Number of subjects: 38
Study 32969489 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 4 mg kg−1
Number of subjects: 38
Study 32645163 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical function impairment (Short Physical Performance Battery score ≤10)
Number of subjects: 266
Study 32645163 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty
Number of subjects: 266
Study 32645163 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefrailty
Number of subjects: 266
Study 32645163 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, black race, greater BMI, and physical inactivity
Number of subjects: 266
Study 32645163 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression and hypertension
Number of subjects: 266
Study 34980467 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundoplication without esophagocrural sutures
Number of subjects: 106
Study 34980467 — intervention group
Group type: COMPARATOR
Intervention: Fundoplication with esophagocrural sutures
Number of subjects: 106
Study 34268630 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-crown restorations supported by short implants
Number of subjects: 40
Study 34268630 — intervention group
Group type: COMPARATOR
Intervention: Standard length implants in conjunction with maxillary sinus floor augmentation (MSFA)
Number of subjects: 40
Study 32891918 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 138
Study 32891918 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 138
Study 32891918 — intervention group
Group type: COMPARATOR
Intervention: Low working memory capacity
Number of subjects: 138
Study 34391724 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT)
Number of subjects: 102
Study 34391724 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 102
Study 34391724 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 33941638 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids and nebulised epinephrine for bronchiolitis
Number of subjects: 0
Study 33941638 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32519824 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern/interactive nutrition education methods
Number of subjects: 170
Study 32519824 — intervention group
Group type: COMPARATOR
Intervention: Traditional/informative nutrition education methods (Control)
Number of subjects: 170
Study 34154557 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 428
Study 34154557 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of FA
Number of subjects: 428
Study 34154557 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors associated with FA knowledge
Number of subjects: 428
Study 34154557 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors affecting FA intake before pregnancy
Number of subjects: 428
Study 36217068 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (adding an anti‐staphylococcal beta‐lactam)
Number of subjects: 266
Study 36217068 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (vancomycin monotherapy)
Number of subjects: 266
Study 36217068 — intervention group
Group type: EXPERIMENTAL
Intervention: (Flu)cloxacillin as the companion beta‐lactam
Number of subjects: 266
Study 36217068 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin area under the concentration–time curve
Number of subjects: 266
Study 34111095 — intervention group
Group type: EXPERIMENTAL
Intervention: Exer-gaming group (EGG) (n=15)
Number of subjects: 30
Study 34111095 — intervention group
Group type: COMPARATOR
Intervention: Traditional training (TBT) group (n=15)
Number of subjects: 30
Study 32674956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 54
Study 32674956 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 54
Study 34958364 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention with free meat substitutes for 4 weeks, information about benefits of eating less meat, success stories, and recipes.
Number of subjects: 115
Study 34958364 — intervention group
Group type: COMPARATOR
Intervention: Control group received no intervention or advice on dietary change.
Number of subjects: 115
Study 33028054 — intervention group
Group type: COMPARATOR
Intervention: SRP plus PVP-I 0.1% irrigant
Number of subjects: 36
Study 33028054 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus BA 0.5% irrigant
Number of subjects: 36
Study 32168290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based Decision Support Tool (DST)
Number of subjects: 109
Study 32168290 — intervention group
Group type: COMPARATOR
Intervention: Memory alone
Number of subjects: 109
Study 34817445 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 5 Hz‐rTMS
Number of subjects: 8
Study 34817445 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 8
Study 34024532 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Energy Restriction (MER)
Number of subjects: 11
Study 34024532 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe Energy Restriction (SER)
Number of subjects: 11
Study 34024532 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate refeed after Severe Energy Restriction
Number of subjects: 11
Study 32429977 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin vaginal gel (400 IU per night)
Number of subjects: 96
Study 36167610 — intervention group
Group type: EXPERIMENTAL
Intervention: MINST + PACNs
Number of subjects: 46
Study 36167610 — intervention group
Group type: COMPARATOR
Intervention: MINST
Number of subjects: 46
Study 34671971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cryoprecipitate transfusion (two pools within 90 minutes of first red blood cell unit requested plus standard care)
Number of subjects: 180
Study 34671971 — intervention group
Group type: COMPARATOR
Intervention: Standard care (cryoprecipitate administered later or not at all)
Number of subjects: 180
Study 34671971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cryoprecipitate transfusion
Number of subjects: 180
Study 34022880 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized surgery combined with radiotherapy and triamcinolone acetonide injection
Number of subjects: 67
Study 32163845 — intervention group
Group type: EXPERIMENTAL
Intervention: ePED iPad application
Number of subjects: 395
Study 32163845 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge teaching (Control)
Number of subjects: 395
Study 34634368 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (FSGTC plus imrecoxib)
Number of subjects: 180
Study 34634368 — intervention group
Group type: EXPERIMENTAL
Intervention: FSGTC group (FSGTC plus imrecoxib placebo)
Number of subjects: 180
Study 34634368 — intervention group
Group type: COMPARATOR
Intervention: Imrecoxib group (imrecoxib plus FSGTC placebo)
Number of subjects: 180
Study 33215562 — intervention group
Group type: EXPERIMENTAL
Intervention: Glasdegib plus low-dose cytarabine (LDAC)
Number of subjects: 0
Study 33215562 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cytarabine (LDAC) alone
Number of subjects: 0
Study 33176210 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy
Number of subjects: 0
Study 33176210 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative approach
Number of subjects: 0
Study 32053110 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified cannabidiol (CBD) (Epidiolex®)
Number of subjects: 4
Study 33771819 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 708
Study 33771819 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 708
Study 33877325 — intervention group
Group type: EXPERIMENTAL
Intervention: MWM
Number of subjects: 45
Study 33877325 — intervention group
Group type: EXPERIMENTAL
Intervention: MWMtape
Number of subjects: 45
Study 33877325 — intervention group
Group type: COMPARATOR
Intervention: MOB
Number of subjects: 45
Study 35325085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 6774
Study 35325085 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 6774
Study 33001140 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of baricitinib once daily (n=111)
Number of subjects: 329
Study 33001140 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of baricitinib once daily (n=109)
Number of subjects: 329
Study 33001140 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=109)
Number of subjects: 329